247 related articles for article (PubMed ID: 8075631)
1. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.
Stratton MR; Ford D; Neuhasen S; Seal S; Wooster R; Friedman LS; King MC; Egilsson V; Devilee P; McManus R
Nat Genet; 1994 May; 7(1):103-7. PubMed ID: 8075631
[TBL] [Abstract][Full Text] [Related]
2. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
3. [Hereditary predisposition for cancer of the breast and the ovary].
Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
[TBL] [Abstract][Full Text] [Related]
5. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
[TBL] [Abstract][Full Text] [Related]
6. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer.
Cortessis V; Ingles S; Millikan R; Diep A; Gatti RA; Richardson L; Thompson WD; Paganini-Hill A; Sparkes RS; Haile RW
Cancer Res; 1993 Nov; 53(21):5083-6. PubMed ID: 8221639
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 susceptibility markers and postmenopausal breast cancer: the Iowa Women's Health Study.
Thompson JA; Chen PL; King RA; Rich SS; Oetting WS; Armstrong C; Folsom AR; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):507-11. PubMed ID: 10815696
[TBL] [Abstract][Full Text] [Related]
8. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
Rahman N; Teare MD; Seal S; Renard H; Mangion J; Cour C; Thompson D; Shugart Y; Eccles D; Devilee P; Meijers H; Nathanson KL; Neuhausen SL; Weber B; Chang-Claude J; Easton DF; Goldgar D; Stratton MR
Oncogene; 2000 Aug; 19(36):4170-3. PubMed ID: 10962578
[TBL] [Abstract][Full Text] [Related]
9. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
10. [Molecular genetics of hereditary breast carcinoma].
Hampl M; Chang-Claude J; Schwarz P; Saeger HD; Schackert HK
Zentralbl Chir; 1997; 122(2):67-73. PubMed ID: 9173760
[TBL] [Abstract][Full Text] [Related]
11. An investigation to determine whether clusters of cancer types exist in nine breast-ovary families.
Bansal A; Bishop DT; Cannings C
Genet Epidemiol; 1995; 12(6):841-6. PubMed ID: 8788019
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
[TBL] [Abstract][Full Text] [Related]
13. [The importance of genetic factors for development of breast cancer].
Chang-Claude J; Eby N; Becher H
Zentralbl Gynakol; 1994; 116(12):660-9. PubMed ID: 7846977
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
15. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
16. The search for the familial breast/ovarian cancer gene.
Black DM; Solomon E
Trends Genet; 1993 Jan; 9(1):22-6. PubMed ID: 8434413
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
18. Analysis of breast cancer pedigrees using affected sibship methods.
Barrett JH; Rigby AS
Genet Epidemiol; 1995; 12(6):847-51. PubMed ID: 8788020
[TBL] [Abstract][Full Text] [Related]
19. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
[TBL] [Abstract][Full Text] [Related]
20. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
Foulkes WD; Narod SA
Clin Invest Med; 1995 Dec; 18(6):473-83. PubMed ID: 8714791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]